RxDoctor Payments Data

Non Product Specific: cost and payments to doctors

What Medicare Part D paid pharmacies for Non Product Specific, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 20192025.

Was your doctor paid by Roche Diagnostics Corporation?

Roche Diagnostics Corporation reported the most payments naming Non Product Specific. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$111K
Providers
39
Transactions
45
Average per transaction
$2,476

The per-transaction average — $2,476 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 39 providers the average total is $2,857, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Roche Diagnostics Corporation$95,63785.8%
Boehringer Ingelheim International GmbH$6,7466.1%
Boehringer Ingelheim (china) Investment Co., Ltd.$6,5505.9%
Boehringer Ingelheim Mexico SA De CV$2,5012.2%

Other products from Roche Diagnostics Corporation

The company that reported the most payments naming Non Product Specific also reports against these.

← All drugs & devices